Cingulate Director Gets 15,000 Stock Options at $4.14 Strike Price
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Director John A. Roberts of Cingulate was granted 15,000 stock options on June 20, 2025. The stock options have the following key terms:
- Exercise price set at $4.14 per share
- Expiration date of June 20, 2035 (10-year term)
- Vesting occurs at earlier of: - One-year anniversary of grant date - Date of Cingulate's 2026 annual stockholder meeting
This Form 4 filing, signed by Attorney-in-Fact Shane J. Schaffer on June 23, 2025, represents standard non-employee director equity compensation. The options provide Roberts with the right to purchase up to 15,000 shares of Cingulate common stock once vested. This grant aligns the director's interests with those of shareholders through long-term equity ownership potential.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to Buy) | 15,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2026 annual meeting of stockholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did CINGW director John A. Roberts receive on June 20, 2025?
When do the stock options granted to CINGW's director Roberts vest?
Who is John A. Roberts and what is his role at CINGW?
What was the total value of stock options granted to CINGW's director in this Form 4?
Where is CINGW's director John A. Roberts located?
AI-generated analysis. How Rhea-AI works. Not financial advice.